Francisco
Marin Ortuño
Profesores Titulares de Universidad Vinculados H.V.Arrixaca
Hospital Universitario Virgen de la Victoria
Málaga, EspañaPublications in collaboration with researchers from Hospital Universitario Virgen de la Victoria (29)
2024
-
Atorvastatin Effect on Aortic Dilatation and Valvular Calcification Progression in Bicuspid Aortic Valve (BICATOR): A Randomized Clinical Trial
Circulation, Vol. 149, Núm. 25, pp. 1938-1948
-
Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR study
Journal of Geriatric Cardiology, Vol. 21, Núm. 7, pp. 723-732
-
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)
Journal of Clinical Medicine, Vol. 13, Núm. 9
2023
-
Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment
American Journal of Cardiology, Vol. 203, pp. 122-127
-
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban
Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049
-
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)
Journal of Clinical Medicine, Vol. 12, Núm. 2
-
Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry
Frontiers in Endocrinology, Vol. 14
2022
-
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry
Journal of the American Heart Association, Vol. 11, Núm. 13
-
Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry
Europace, Vol. 24, Núm. 2, pp. 202-210
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study
Cardiology Journal, Vol. 29, Núm. 6, pp. 936-947
-
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 1, pp. 38-46
-
Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study
European Journal of Clinical Investigation
-
Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 1, pp. 4-11
2021
-
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])
Critical Care Medicine, Vol. 49, Núm. 6, pp. E624-E633
-
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry
Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615
-
COVID-19 and the impact of arterial hypertension—An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany)
European Journal of Clinical Investigation, Vol. 51, Núm. 11
-
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
Infection, Vol. 49, Núm. 4, pp. 677-684
-
Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction
Journal of the American College of Cardiology, Vol. 78, Núm. 7, pp. 643-662
-
Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19
European Journal of Clinical Investigation, Vol. 51, Núm. 1